Patents by Inventor Christine WILKINSON BLANC

Christine WILKINSON BLANC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSING REGIME AND FORMULATIONS FOR TYPE B ADENOVIRUSES
    Publication number: 20220054563
    Abstract: The present disclosure provides a method of treating a human patient comprising the steps of: systemically administering multiple doses of a parenteral formulation of a replication capable oncolytic adenovirus of subgroup B in a single treatment cycle, wherein the total dose given in each dose is in the range of 1×1010 to 1×1014 viral particles, and wherein each dose of virus is administered over a period of 1 to 90 minutes, for example at a rate of viral particle delivery in the range of 2×1010 particles per minute to 2×1012 particles per minute. The disclosure further extends to formulations of the said oncolytic adenoviruses and combination therapies of the viruses and formulations with other therapeutic agents.
    Type: Application
    Filed: September 23, 2021
    Publication date: February 24, 2022
    Inventors: John Beadle, Kerry Fisher, Christine Wilkinson Blanc
  • Dosing regime and formulations for type B adenovirus
    Patent number: 11173186
    Abstract: A method of treating a human patient comprising systemically administering multiple doses of a parenteral formulation of a replication capable oncolytic adenovirus of subgroup B in a single treatment cycle, wherein the total dose given in each dose is in the range of 1×1010 to 1×1014 viral particles, and wherein each dose of virus is administered over a period of 1 to 90 minutes, for example at a rate of viral particle delivery in the range of 2×1010 particles per minute to 2×1012 particles per minute. Also provided are formulations of the oncolytic adenoviruses and combination therapies of the viruses and formulations with other therapeutic agents.
    Type: Grant
    Filed: June 12, 2014
    Date of Patent: November 16, 2021
    Assignee: PSIOXUS THERAPEUTICS LIMITED
    Inventors: John William Beadle, Kerry Fisher, Christine Wilkinson Blanc
  • A Dosing Regime and Formulations for Type B Adenovirus
    Publication number: 20160120922
    Abstract: The present disclosure provides a method of treating a human patient comprising the steps of: systemically administering multiple doses of a parenteral formulation of a replication capable oncolytic adenovirus of subgroup B in a single treatment cycle, wherein the total dose given in each dose is in the range of 1×1010 to 1×1014 viral particles, and wherein each dose of virus is administered over a period of 1 to 90 minutes, for example at a rate of viral particle delivery in the range of 2×1010 particles per minute to 2×1012 particles per minute. The disclosure further extends to formulations of the said oncolytic adenoviruses and combination therapies of the viruses and formulations with other therapeutic agents.
    Type: Application
    Filed: June 12, 2014
    Publication date: May 5, 2016
    Inventors: John William BEADLE, Kerry FISHER, Christine WILKINSON BLANC